HEALTHSEMAFOR
Africa moves ahead with vaccine manufacturing ambitions
Africa aims to produce 60% of its vaccines locally by 2040, supported by Gavi's $1.2 billion African Vaccine Manufacturing Accelerator. Initial disbursements to African manufacturers are expected in 2026, alongside efforts to secure technology transfer agreements and long-term funding for sustainable production.
Mentioned
Related Signal
Adjacent reporting
- China’s first AI-powered cancer vaccine production line set to launch in Beijing
- Moderna gets $50M investment for Ebola vaccine candidate
- CEPI invests $1.9m to accelerate Ebola Vaccine development
- China’s first AI-powered cancer vaccine production line set to launch in Beijing
- Healthy Returns: Eli Lilly makes a new push into vaccines – here’s what to know
- Congo-Kinshasa: Unicef and Gavi Launch Call to Manufacturers in Support of Accelerated Access to Bundibugyo Ebolavirus Vaccines